Today's Top Gainer
Note:Top Gainer - Nifty 50 More
So far the promoters have pledged 56 lakh shares, or 5.06% of the total share capital, of Wockhardt.
Wockhardt reported a consolidated net loss of Rs 94.24 crore in Q2 September 2019, higher than net loss of Rs 30.84 net loss in Q2 September 2018. Net sales dropped 28.7% to Rs 802.18 crore during the said period.
The result was announced on 7 November 2019. Since the announcement of result, the stock has tumbled 15.56%.
The stock currently trades below its 50-day simple moving average (DMA) placed at 277.33. It was also below its 200 DMA placed at 349.69.
Wockhardts businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.
Powered by Capital Market - Live News